Advertisement

Topics

VetDC Announces Commercial Launch of TANOVEA™-CA1 for Lymphoma in Dogs

14:00 EDT 3 Apr 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
VetDC, Inc., a veterinary cancer therapeutics company, today announced that TANOVEA™-CA1 (rabacfosadine for injection) is now commercially available in the US for purchase by licensed veterinarians. TANOVEA-CA1 was recently gr...

Other Sources for this Article

VetDC, Inc.
Steven J. Roy, President & CEO
Mobile: 303-859-2072
E-mail: info@vet-dc.com

NEXT ARTICLE

More From BioPortfolio on "VetDC Announces Commercial Launch of TANOVEA™-CA1 for Lymphoma in Dogs"

Quick Search
Advertisement
 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...